AIExome V5-Tumor, based on covering over 99.9% of protein-coding regions from databases such as CDS (RefSeq & refGene)*, MANE, and CCDS, additionally includes detection regions for Fusion, MSI, HLA, HRD, and mtDNA. It achieves multi-variant detection needs in a single probe tube and one-time testing, truly realizing All-in-one.
The coverage rate of coding sequence (CDS) regions in AIExome V5-Tumor across multiple databases significantly outperforms competing products.


Data Saving
AIExome V5-Tumor features a unique depth adjustment technology that increases the depth of tumor-related regions by approximately 4 times compared to other exonic regions. Specifically, with 10 Gb of data and an average depth of 100× across the whole exome region, the depth for tumor-related genes can reach approximately 400×.
Sensitivity
While saving data volume and increasing depth, the high-depth tumor-related regions enable accurate detection of low-frequency mutations.
